TMEM97 and ovarian carcinoma: This suggests a mechanism to explain a decade of data demonstrating that σ2R/TMEM97 correlates with worse outcomes in a variety of solid tumors, including gastric (84), non–small cell lung (85, 86), squamous cell lung (87), and ovarian cancers (88).